Cases
Representative Matters: Represented Nasdaq software simulation company in its 115M public offering underwritten by Oppenheimer
Raymond James
Represented majority shareholders in their sale of medical device company in a 100M sale to leading Nasdaq healthcare company.
Represented majority shareholders of healthy snack company in its 340M sale to an international food br
.
Represented soils
construction materials firm in its 14M sale to a larger competitor.
Represented the largest privately held nurse staffing company in its 40M acquisition of a national provider of healthcare workforce solutions.
Represented medical supply company in its 160M sale to a leading healthcare private equity firm.
Represented behavioral health company in its 33M sale to a leading private equity construction firm.
Represented nonprofit better business organization in its merger with a regional nonprofit better business organization.
Represented Nasdaq software simulation company in its acquisitions of a French software solution company, a clinical trial data analysis company,
a drug -induced liver analysis company collectively valued at over 30M.
Represented high performance computing company in its 20M Initial Public Offering
listing on Nasdaq.
Represented bakery in its 8M acquisition of bakery
food manufacturing company.
Represented leasing platform housing company in its 250M sale to a leading Nasdaq provider of real estate software
data analytics company.
Represented golf simulation company in its 30M sale to a private equity firm
golf manufacturing company.
Represented high end hunting gear company in its 50,000,000 sale of minority interest to leading private consumer growth equity firm.
Represented nutrition bar company in significant private equity investment from leading food
br
firm.
Represented Irish pharmaceutical company in 2.5B merger with a NASDAQ pharmaceutical company.
Represented vegan restaurant chain in several of its acquisition
fundings of new restaurants.
Represented Irish pharmaceutical company in 87M secondary public offering of shares in a NASDAQ pharmaceutical company.
Represented high quality pizza restaurant chain in several of its acquisitions
financing of new locations
concepts.
Represented minority shareholders in 800M sale of publishing enterprise to entertainment company.
Represented medical device manufacturer in 30M sale to German acquirer.
Represented biofuels company in 10.5M industrial development bond refinancing.
Represented management in their 165M buyout of the US operations of a large London Stock Exchange homebuilder.
Represented NYSE company in acquisition of 50 cash advance companies in Southern California.
Represented a large public company bank in its 25M investment in a regional investment banking firm.
Represented Italian biotech company in significant licensing/stock deal with NASDAQ biopharma company.
Represented Internet lead generation business in its sale to a national competitor.
Represented a design engineering firm in its 20M sale to a public company strategic buyer.
Represented large privately held fitness center chains
owners in connection with sales of over 75 US
Asian fitness centers in two transactions valued at over 100M.
Represented major fruit
vegetable distributor in its 30M sale to strategic competitor.
Represented NASDAQ technology company in connection with its sale of a 75M Mexican subsidiary to a NYSE company.
Represented Internet-based information technology company in connection with its 30M acquisition by a NASDAQ-listed company.
Represented a beef processing plant in its 100M sale to public company competitor.
Represented organic food company in its acquisition of smaller competitor.
Represented underwriter in initial public offering of organic food company.
Represented organic pasta company in its initial public offering.
